Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of KPL-404 in Healthy Subjects
Clinical trial NCT04497662 · COMPLETED
Trial details
- NCT number
- NCT04497662
- Sponsor
- Kiniksa Pharmaceuticals, Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-22
- Primary completion
- 2021-01-21
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.